Evidence mapPaperPMID 32148732Full record

ArticleFamily medicine and community health2020

Effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau: a quality improvement study.

In Wong, See Fai Tse, Chau Sha Kwok

Open access · diamondAbstract read
In one paragraph

Article in Family medicine and community health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

In WongHealth Bureau, Macau SAR Government, Macau, China.
See Fai TseHealth Bureau, Macau SAR Government, Macau, China.
Chau Sha KwokHealth Bureau, Macau SAR Government, Macau, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The objective of this study was to test the effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau. Design: A quality improvement study based on an evaluation of a before-after intervention trial was conducted in 2017-2018. Interventions comprising feedback from an audit, general practitioner (GP) training via interactive workshops and one-on-one case discussions were implemented. The primary outcome measure was the proportion of patients with reasonable management of dyslipidaemia, and the secondary outcome measure was the proportion of patients with low-density lipoprotein cholesterol (LDL-C) meeting the target recommended by the Adult Treatment Panel III guidelines. Setting: This study was conducted at the Sao Lourenco Health Center, one of the health centres in the Macau primary care system; this centre provides primary care services to one-tenth of the residents of Macau. Participants: All GPs who worked in the Sao Lourenco Health Center participated in the study. We systematically reviewed 100 patient records from each participating physician's patient list. In total, 1200 and 1100 patient records were reviewed before and after the intervention, respectively. Results: At baseline, 390 (43.5%) patients were eligible for statin therapy, while 411 (47.7%) patients were eligible for statin therapy in the reaudit group (p=0.08). After intervention, the proportion of patients with reasonable management of dyslipidaemia increased from 83.9% to 88.5% (p=0.005), and the proportion of eligible patients with LDL-C levels meeting the target increased from 55.1% to 65% (p=0.004). Conclusions: The audits and feedback significantly improved dyslipidaemia management in the Macau primary care setting.

Indexed as

Medical AuditPrimary Health CareAgedCholesterol, LDLDyslipidemiasFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMacauMaleMiddle AgedQuality ImprovementTreatment OutcomeCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsATP III guidelinesclinical auditdyslipidemiasquality improvement

Identifiers

PMID32148732
PMCPMC7046378
OpenAlexW3008893366

What Socratic holds

Texttitle and abstract
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.